Navigation Links
Ovarian cancer in relationship with Hormone therapy

A major US study has found that women who have taken postmenopausal oestrogens for ten years or more are at substantially greater risk of fatal ovarian cancer.

The risk persists for many years after therapy is discontinued, researchers from the American Cancer Society report// in the Journal of the American Medical Association.The study followed 201,681 postmenopausal women from 1982 to 1996 and found ERT (oestrogen replacement therapy) increased the risk and this persisted for up to 29 years after women stopped using it.

Twenty two percent of the women in the study had used ERT, including 11,024 who were users at the start of the study (baseline users) and 35,236 who were former users. A total of 944 ovarian cancer deaths were recorded in the 14 year study until December 1996.

Researchers found the risk of death was approximately doubled in women who had used oestrogens for ten or more years within the 15 years prior to enrolment. Annual age-adjusted ovarian cancer death rates per 100,000 women were 64.4 for baseline users with 10 or more years of use, 38.3 for former users with 10 or more years of use, and 26.4 for never users.

Women who were using ERT at baseline had 51 percent higher death rates from ovarian cancer than those who never used ERT. Among former oestrogen users, the risk was 16 percent higher - a slight, but not significant increase. However, women who had used ERT for less than 10 years had no greater risk.

Postmenopausal oestrogen is already known to increase the risk of endometrial and breast cancer when used for a long time, but until this study, the effect of postmenopausal oestrogen use on ovarian cancer had not established.


'"/>




Page: 1

Related medicine news :

1. Exercise lowers Risk of Ovarian Cancer
2. Gene Mutation Causes Ovarian Failure
3. Ovarian Cancer Screening Questioned
4. Thawed Ovarian Transplant
5. The Benefits Of Chemotherapy For Women With Ovarian Cancer
6. Progesterone Found To Increase Ovarian Cancer Risk
7. Developmental Origins of Polycystic Ovarian Syndrome
8. Polycystic Ovarian Syndrome(PCOS) linked to Diabetes
9. Ovarian cancer risk reduced by regular exercise
10. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
11. Genetic Profile To Predict Ovarian Cancer Prognosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... Vail, Colorado (PRWEB) , ... February 12, 2016 , ... ... 164 ASC Industry Physician Leaders to Know in 2016 . The list consists of ... leaders nominated physicians to establish this list. , An Ambulatory Surgery Center, also ...
(Date:2/12/2016)... CA (PRWEB) , ... February 12, 2016 , ... Donor ... in northern California and Nevada, announced a partnership with San Ramon Regional Medical Center. ... to the hospital’s facilities as a way to accommodate a more certain time frame ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... surrounding communities by continuing it’s commitment to act as Agents of Change in ... works closely with area homeless families to fulfill immediate needs and help them ...
(Date:2/12/2016)... DC (PRWEB) , ... February 12, 2016 , ... ... “Managing High-Cost Drug Categories: Strategies for Health Plans and PBMs,” an upcoming Feb. ... to maintain affordability and access in big-dollar therapeutic categories, such as the $1,000-per-pill ...
(Date:2/12/2016)... ... , ... A lot has been reported about the fitness routines of United ... and wellness resources most Americans could ever dream of having at their disposal. However, ... frenetic as the U.S. President. , In honor of President’s Day on Feb. ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 2016 Stem cells are primitive cells found ... and the capacity to differentiate into mature cell types ... the first mouse embryonic stem cells were derived from ... that the first culturing of embryonic stem cells from ... produced until 2006 As a result of these discoveries, ...
(Date:2/11/2016)... 11, 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ... the lives of pets, today announced the submission to ... Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  ... of Zimeta for the control of pyrexia (fever) in ... --> --> The Chemistry, Manufacturing, ...
(Date:2/11/2016)... , Feb. 11, 2016   Health 2.0 ... of new health technologies, announced today " 10 Year ... in health tech over the past ten years.   ... nearly a decade, Health 2.0 has served as the ... and connected with thousands of technologies, companies, innovators, and ...
Breaking Medicine Technology: